Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,186,960
Closed -$4.3M 7
2023
Q2
$4.3M Hold
2,186,960
0.12% 6
2023
Q1
$4.22M Buy
+2,186,960
New +$5.48M 0.11% 7
2022
Q3
Sell
-425,726
Closed -$1.21M 7
2022
Q2
$1.21M Hold
425,726
0.05% 8
2022
Q1
$1.93M Hold
425,726
0.05% 8
2021
Q4
$3.46M Hold
425,726
0.08% 9
2021
Q3
$5.37M Hold
425,726
0.12% 8
2021
Q2
$6.59M Hold
425,726
0.15% 7
2021
Q1
$8.6M Hold
425,726
0.22% 6
2020
Q4
$11.5M Hold
425,726
2.09% 5
2020
Q3
$7.88M Buy
+425,726
New +$7.55M 2.26% 5

Other funds holding CLLS

Bpifrance's CLLS Position: Q3 2023 in Review

Bpifrance sold out of Cellectis (CLLS) in Q3 2023, closing a stake of 2,186,960 shares — an estimated $4.3M sold.

Bpifrance first reported a position in CLLS in Q3 2020 and held it in 10 quarters. The position peaked at $11.5M in Q4 2020. 30 funds tracked by Wall St. Rank hold CLLS as of Q3 2023.

  • Bpifrance reported no remaining Cellectis position as of Q3 2023 after selling out during the quarter.
  • Bpifrance sold 2,186,960 Cellectis shares in Q3 2023, an estimated $4.3M.
  • Bpifrance first reported a position in Cellectis in Q3 2020 and held it in 10 quarters.
  • Bpifrance's Cellectis position peaked at $11.5M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Cellectis as of Q3 2023.

Based on Bpifrance's 13F filing for Q3 2023, filed 13 Nov 2023.